We provide a detailed directory of the different tests that are offered, including information such sample collection instructions, test requirements and turnaround time.
Antibody testing for the purposes of diagnosing Myasthenia Gravis has been offered at BC Neuroimmunology since 1984.
Chronic Inflammatory Demyelinating Polyneuropathy
CIDP is an acquired, degenerative autoimmune disorder that affects the peripheral nervous system.
Neuromyelitis optica (NMO) is an autoimmune, inflammatory disorder of the central nervous system that affects the optic nerves and spinal cord.
Lambert-Eaton Myasthenic Syndrome
We use a radioimmunoassay kit that is FDA-cleared for in vitro diagnostic used to semi-quantitatively measure antibodies to voltage-gated calcium channels in human serum.
There are several targets for autoimmune antibody-mediated encephalitis with the most common being N-methyl-D-aspartate receptor (NMDAR).
Paraneoplastic neurological syndromes (PNS) are rare, but potentially treatable disorders of the nervous system that are associated with cancer.
Neutralizing Antibodies to Interferon-beta
Interferon-beta is the first immunomodulatory drug shown to change the natural history of multiple sclerosis. Several recombinant preparations are currently available.